ArticleOncoTargets and therapy2014

Nimotuzumab plus chemotherapy versus chemotherapy alone in advanced non-small-cell lung cancer: a multicenter, randomized, open-label Phase II study.

K Govind Babu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.